While enhanced IGFBP7 expression promoted resistance to EGFR-TKIs in lung cancer cells, IGF-1R activation has been reported to confer acquired resistance to EGFR-TKIs [19,20,21]. The gene discussed is IGF1R; the disease is lung cancer.